Many of the Broad's technologies are available to license. Below we have highlighted technologies from the Broad Institute that have recently been featured in scientific publications and press releases. If you are interested in finding out about other technologies not listed below, please contact the Office of Strategic Alliances and Partnering (firstname.lastname@example.org).
Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 2014.
Genetic Screens in Human Cells Using the CRISPR/Cas9 System, Science, 2014.
Identification of small molecules for human hepatocyte expansion and iPS differentiation, Nature Chemical Biology, 2013.
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells, Nature chemical biology, 2013.
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nature Biotechnology, 2013.
Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: IV. viral proteinase slides along DNA to locate and process its substrates, Journal of Biological Chemistry, 2013.
Multiplex genome engineering using CRISPR/Cas systems, Science, 2013.
Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains, Nature Communications, 2012.
Absolute quantification of somatic DNA alterations in human cancer, Nature Biotechnology, 2012.
RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities, Proceedings of the National Academy of Sciences of the United States of America, 2012.